Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives
Sunday, August 28, 2011 - 04:00
in Health & Medicine
A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in substantially less bleeding and also results in lower mortality.